Literature DB >> 12820315

Criteria for the selection of referential groups in tumor marker statistical evaluation on the basis of a retrospective study.

L Holubec1, O Topolcan, R Pikner, L Pecen, L Holubec Sen, J Finek, M Ludvikova, M Cerna.   

Abstract

The authors of this study are concerned with the analysis of optimal criteria for the selection of referential groups in the statistical evaluation of tumor markers for early detection of recurrent disease. Although criteria for the selection of optimal referential groups have already been published on a number of occasions (EGTM recommendation), these criteria are not followed in daily routine, which leads to a false interpretation of results and the impossibility of comparing individual studies. The commonest problem is an incorrect determination of cut-off, caused by not following the recommended specificities at 95%, which results in an incorrect assessment of tumor marker sensitivities. Other faulty interpretations happen in consequence of inaccurate and not clearly defined referential groups, which differ from each other by, for example, stage of the disease, length of the follow-up and so on. Comparing tumor marker results still remains a problem, since they are assessed with diagnostic kits from different manufacturers which may misrepresent the final value of the results, and thus imitate remission or progression of the tumor disease. Similarly, mutual comparison of results from prospective and retrospective studies without standardization of clinical conditions leads to an unreliable interpretation. The authors show, through concrete examples, the possibility of a completely different interpretation of the results in identical referential groups in consequence of their inaccurate characteristics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12820315

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Survival in Resected Stage II Colorectal Cancer Is Dependent on Tumor Depth, Vascular Invasion, Postoperative CEA Level, and The Number of Examined Lymph Nodes.

Authors:  Hsiang-Lin Tsai; Ching-Wen Huang; Chao-Wen Chen; Yung-Sung Yeh; Cheng-Jen Ma; Jaw-Yuan Wang
Journal:  World J Surg       Date:  2016-04       Impact factor: 3.352

2.  Predictive factors and the prognosis of recurrence of colorectal cancer within 2 years after curative resection.

Authors:  Jong Pil Ryuk; Gyu-Seog Choi; Jun Seok Park; Hye Jin Kim; Soo Yeun Park; Ghil Suk Yoon; Soo Han Jun; Yong Chul Kwon
Journal:  Ann Surg Treat Res       Date:  2014-02-24       Impact factor: 1.859

3.  The Clinical Significance of Mesenteric Lymphocytes in Human Colorectal Cancer.

Authors:  Zi-Xin Wu; Fei Wang; Liang Li; Yuan Yao; Jie Long; Qing-Qing Luo; Zhi-Bin Zhao; Wang-Lin Li; Jie Cao; Zhe-Xiong Lian
Journal:  Front Oncol       Date:  2021-09-16       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.